AVE 33.3% 0.2¢ avecho biotechnology limited

new ceo and board 'business model', page-40

  1. 3,266 Posts.
    lightbulb Created with Sketch. 86
    If she was passed on for the ceo appointment, POH must be setting their bar extremely high.

    "...consider that Sally expected to get the CEO job and was passed over so has decided to move on?..."

    With possibly 2 weeks as COO when Esragate started, I would not think she herself would have expected to get the CEO position. 3 months on, she may have had discussions with the board (god help her there) and they passed her over or she passed up the offer - only those in the know will know. Unfortunately, we may have the wrong board making the decision to appoint the ceo.



 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.